Analysis of the transcriptome in molecular epidemiology studies

Area of Science:

• Molecular Biology
• Genomics
• Environmental Health

Background:

• The human transcriptome is highly complex, featuring diverse RNA types like long non-coding RNA (lncRNA), crucial for gene regulation.
• Environmental exposures can disrupt transcriptome integrity, impacting health.
• Next-generation RNA sequencing (RNA-Seq) is a powerful tool for transcriptome analysis but has inherent limitations.

Purpose of the Study:

• To review the complexity of the human transcriptome and its regulation.
• To discuss the application and limitations of transcriptomic technologies (RNA-Seq, microarray) in molecular epidemiology.
• To highlight the importance of standardized methodologies and robust study designs for identifying exposure biomarkers and understanding disease mechanisms.

Main Methods:

• Review of existing literature on human transcriptome complexity, RNA sequencing, and molecular epidemiology.
• Discussion of the MAQC-III (SeQC) project's role in standardizing transcriptomic methodologies.
• Exploration of toxicogenomic studies utilizing RNA-Seq.

Main Results:

• Transcriptomic analysis, particularly RNA-Seq, offers insights into gene regulation and environmental exposure effects.
• Limitations in transcriptomic studies include cell/tissue type choice, experimental variability, and confounding factors.
• Standardization efforts (e.g., SeQC) and pathway-level analysis can mitigate some limitations.

Conclusions:

• Well-designed molecular epidemiology studies with precise exposure data and phenotypic anchors can reveal exposure biomarkers and disease mechanisms.
• Transcriptomics, when applied rigorously, can elucidate the link between environmental exposures and disease, even at low doses.
• Future transcriptomic datasets and pathway analysis will enhance understanding of the exposure-disease continuum.